EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comSeveral trends, including the launch of innovative specialty drugs, regulatory and pricing pressure, and alternative payment models, are transforming the drug development landscape as we know it. Technological disruptions like predictive analytics are impacting the way clinical trial processes are shaped and executed. Alongside, rapid advancements in biotechnologies, such as gene-editing and next-generation DNA sequencing, are emerging as promising solutions to treat chronic illnesses. There is also an increasing interest in the use of DNA-encoded libraries--small molecules tagged with DNAs--by major pharma companies for screening millions, billions, and even trillions of chemical compounds in a single, simple experiment. DNA-encoded libraries are becoming the go-to resource for finding new drug candidates and research tools for large pharmaceutical companies, small biotechs, and academics alike.In the light of all these trends, APAC region is emerging as a preferred destination for outsourcing drug discovery activities due to its vast availability of skilled manpower, lower costs, favorable regulatory environment, and quality data. In particular, the Chinese and Indian pharmaceutical markets are gaining prominence because of the end-to-end technological capabilities that the nation's pharma sector has developed over several years. Amid these exciting changes, the drug discovery landscape is in great demand of trusted advisers that can navigate the path ahead. Acknowledging the need, Pharma Tech Outlook presents this edition of the magazine, featuring some of the most prominent organizations around the globe that are revolutionizing the drug development landscape with their innovative services. We hope the services offered by the featured companies as well as valuable CXO standpoints from industry thought leaders help you get a better picture of current drug discovery landscape and where it is headed.Let us know your thoughts!Conquering the Challenges of the Pharma IndustryCopyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.September - 11 - 2019, Vol 05 - Issue 11 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasJoshua ParkerJustin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comsales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Albert RozarioTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >